ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Mechanical Engineering Co-op/Intern (Spring 2027) at Multiply Labs - ApplyBlast

Mechanical Engineering Co-op/Intern (Spring 2027)

Multiply Labs

14 days ago

San Francisco, California, United States

Onsite

Internship

Intern

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Multiply Labs is seeking a Mechanical Engineering Co-op/Intern to join their San Francisco team for a full-time position starting in January 2027. The role involves applying engineering skills to design robotic cartridges and consumables for novel pharmaceutical products, working closely with cross-functional hardware and software teams. The intern will be responsible for optimizing designs, creating prototypes, and driving projects from concept to production.

Responsibilities

Design and build robotic cartridges and consumables for pharmaceutical manufacturing
Create supporting design documentation including 3D CAD models and detailed drawings
Prototype, test, and iterate on designs using first-principles engineering approaches

Skills

Qualifications

Bachelor of Science in Mechanical Engineering

About Multiply Labs

multiplylabs.com

Headquarters

San Francisco, California, United States

Company Size

11-50 employees

Founded

2016

View Profile

Multiply Labs builds robotic biomanufacturing infrastructure powered by Physical AI to automate the production of advanced biological therapies, including cell therapies, gene therapies, antibodies, and RNA therapies. Their platform — comprising autonomous robotic clusters, fully automated unit operations, and integrated GMP-compliant software — enables biopharma partners to scale throughput, reduce costs, and eliminate contamination risks associated with manual processes. The company serves life-science organizations seeking to modernize their manufacturing stack for the next generation of complex biological drugs.